These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 30674717

  • 1. Neuron-specific PERK inactivation exacerbates neurodegeneration during experimental autoimmune encephalomyelitis.
    Stone S, Yue Y, Stanojlovic M, Wu S, Karsenty G, Lin W.
    JCI Insight; 2019 Jan 24; 4(2):. PubMed ID: 30674717
    [Abstract] [Full Text] [Related]

  • 2. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
    Yue Y, Stanojlovic M, Lin Y, Karsenty G, Lin W.
    J Neuroinflammation; 2019 Feb 01; 16(1):23. PubMed ID: 30709400
    [Abstract] [Full Text] [Related]

  • 3. NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE.
    Lei Z, Yue Y, Stone S, Wu S, Lin W.
    J Neurosci; 2020 Aug 12; 40(33):6444-6456. PubMed ID: 32661025
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
    Stanojlovic M, Pang X, Lin Y, Stone S, Cvetanovic M, Lin W.
    PLoS One; 2016 Aug 12; 11(7):e0160158. PubMed ID: 27466819
    [Abstract] [Full Text] [Related]

  • 5. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
    Lin W, Lin Y, Li J, Fenstermaker AG, Way SW, Clayton B, Jamison S, Harding HP, Ron D, Popko B.
    J Neurosci; 2013 Apr 03; 33(14):5980-91. PubMed ID: 23554479
    [Abstract] [Full Text] [Related]

  • 6. Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination.
    Hussien Y, Cavener DR, Popko B.
    Glia; 2014 May 03; 62(5):680-91. PubMed ID: 24481666
    [Abstract] [Full Text] [Related]

  • 7. Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis.
    Das A, Guyton MK, Butler JT, Ray SK, Banik NL.
    CNS Neurol Disord Drug Targets; 2008 Jun 03; 7(3):313-20. PubMed ID: 18673215
    [Abstract] [Full Text] [Related]

  • 8. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
    Lin Y, Huang G, Jamison S, Li J, Harding HP, Ron D, Lin W.
    Am J Pathol; 2014 Feb 03; 184(2):507-19. PubMed ID: 24269558
    [Abstract] [Full Text] [Related]

  • 9. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
    Stone S, Wu S, Jamison S, Durose W, Pallais JP, Lin W.
    Glia; 2018 Jul 03; 66(7):1331-1345. PubMed ID: 29436030
    [Abstract] [Full Text] [Related]

  • 10. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
    Lee JY, Kim MJ, Thomas S, Oorschot V, Ramm G, Aui PM, Sekine Y, Deliyanti D, Wilkinson-Berka J, Niego B, Harvey AR, Theotokis P, McLean C, Strittmatter SM, Petratos S.
    J Neurosci; 2019 Jul 10; 39(28):5562-5580. PubMed ID: 31061088
    [Abstract] [Full Text] [Related]

  • 11. Targeted deletion of PAC1 receptors in retinal neurons enhances neuron loss and axonopathy in a model of multiple sclerosis and optic neuritis.
    Van C, Condro MC, Ko HH, Hoang AQ, Zhu R, Lov K, Ricaflanca PT, Diep AL, Nguyen NNM, Lipshutz GS, MacKenzie-Graham A, Waschek JA.
    Neurobiol Dis; 2021 Dec 10; 160():105524. PubMed ID: 34610465
    [Abstract] [Full Text] [Related]

  • 12. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC, Karim H, Khalaj AJ, Ghosh S, Tiwari-Woodruff SK.
    J Neurosci Methods; 2017 Jun 01; 284():71-84. PubMed ID: 28396177
    [Abstract] [Full Text] [Related]

  • 13. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD.
    J Neuropathol Exp Neurol; 2002 Jan 01; 61(1):23-32. PubMed ID: 11829341
    [Abstract] [Full Text] [Related]

  • 14. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC, Plafker SM.
    Mol Vis; 2016 Jan 01; 22():1503-1513. PubMed ID: 28050123
    [Abstract] [Full Text] [Related]

  • 15. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D.
    J Neuroinflammation; 2016 Aug 26; 13(1):207. PubMed ID: 27566665
    [Abstract] [Full Text] [Related]

  • 16. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Aug 26; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 17. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D.
    Proc Natl Acad Sci U S A; 2007 May 01; 104(18):7558-63. PubMed ID: 17463082
    [Abstract] [Full Text] [Related]

  • 18. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C, Cavallini C, Meyer L, Klein C, Da Pozzo E, Costa B, Germelli L, Taliani S, Patte-Mensah C, Mensah-Nyagan AG.
    Mol Neurobiol; 2022 Mar 01; 59(3):1744-1765. PubMed ID: 35018577
    [Abstract] [Full Text] [Related]

  • 19. Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
    Clark KC, Josephson A, Benusa SD, Hartley RK, Baer M, Thummala S, Joslyn M, Sword BA, Elford H, Oh U, Dilsizoglu-Senol A, Lubetzki C, Davenne M, DeVries GH, Dupree JL.
    Glia; 2016 Jul 01; 64(7):1190-209. PubMed ID: 27100937
    [Abstract] [Full Text] [Related]

  • 20. Exploring experimental autoimmune optic neuritis using multimodal imaging.
    Manogaran P, Walker-Egger C, Samardzija M, Waschkies C, Grimm C, Rudin M, Schippling S.
    Neuroimage; 2018 Jul 15; 175():327-339. PubMed ID: 29627590
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.